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Background 
Cardiovascular disease causes 750,000 deaths annually in the US1 
Valvular heart disease is characterized by abnormal tissue stiffness and 
calcification, stenosis, or thromboembolism of valve leaflets, which can 










A common treatment is replacement with either a mechanical or tissue-








Existing heart valve replacements provide major improvements in 
cardiac function and life expectancy, but have significant limitations and 




 In pediatric patients, mechanical implants are naturally outgrown and  
degradation and calcification of tissue-derived implants is accelerated. 
A tissue engineered heart valve (TEHV) replacement  with the 
capabilities of remodeling and growing with the patient would alleviate 
these problems. 
A device for uniform cell seeding will be required to facilitate the 
development of an autologous TEHV in the areas of: 
 Depositing a confluent layer of cells on all surfaces. 
 Improving cell seeding efficiency and uniformity  
over manual seeding regardless of user variations. 
 Providing conditions under which varying attachment 
improvements can be evaluated and compared. 
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Porcine aortic heart valves were decellularized to remove the porcine-
specific antigens,2 sterilized using peracetic acid, and stabilized with 
pentagalloyl glucose to control tissue degradation. 
Valve surfaces were incubated in 50% serum in cell culture medium 
overnight to neutralize any remaining pentagalloyl glucose molecules 
then coated with Fibronectin or Pronectin to improve cell attachment. 
Valves were mounted in individual seeding chambers, seeded with 15 to 
24 million porcine aortic endothelial cells (pAECs) or human adipose 
derived stem cells (hASCs), and rotated according to multiple regimens. 
Cell seeded valves were placed in a dynamic heart valve bioreactor 
under pulmonary or aortic pressures.  
Valves were evaluated for initial attachment, retention after bioreactor 
testing, and viability throughout. 
Conclusions 
The treated surface was compatible with both cell types. 
Device design and protocol enabled a reproducible & semi-automated seeding process. 
Made progress toward achieving a confluent valvular endothelium layer. 
Cells were retained on the scaffold surface under pulmonary pressure conditioning in 
the bioreactor. 
Surface seeding has been successful with two cell types and is quickly progressing 
toward a translational regenerative TEHV fully seeded with the patient’s own cells. 
A) Bioreactor components B) Endothelial cell seeded TEHV C) Stented bioprosthetic heart valve D) Diagram of conditioning system 
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